Ligand-Functionalized Substrates for Virus Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chromatographic methods for purifying biomaterials, such as viruses, face bottlenecks in throughput and efficiency due to limitations in diffusion and binding affinity, leading to high costs and economic challenges.

Innovation Solution

Development of ligand-functionalized substrates with grafted ligand groups that enhance affinity for neutral or negatively charged biomaterials, allowing for selective binding and removal, using a process involving photoinitiator monomers, ligand monomers, and UV polymerization to create a porous substrate with improved binding capabilities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional column chromatography techniques are used, then separation and purification of biomaterials can be achieved, but throughput is low and bottlenecking occurs in downstream purification

Engineering Contradiction:
ImprovethroughputVSAvoidpurification effectiveness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention divides the chromatographic separation process into multiple parallel flow cells arranged in series, where each cell contains ligand-functionalized beads. This segmentation allows multiple purification operations to occur simultaneously, increasing throughput while maintaining effective separation through the cumulative effect of multiple binding stages

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses porous beads functionalized with ligands that provide high surface area for biomaterial binding. The porous structure increases the effective binding capacity while maintaining appropriate flow characteristics, enabling both high throughput and effective purification

Inventive Principle:
Principle #31Porous materials

2Productivity

If the diameter of the chromatography column is increased to alleviate bottlenecking, then throughput may improve, but packing difficulties and channeling problems increase

Engineering Contradiction:
ImprovethroughputVSAvoidcolumn packing
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

Instead of using a single large-diameter column that is difficult to pack uniformly, the invention segments the system into multiple smaller flow cells connected in series. Each cell can be independently packed with ligand-functionalized beads, avoiding channeling problems while collectively providing the necessary throughput capacity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from a single-column radial flow approach to a multi-cell series arrangement, effectively adding a dimensional aspect to the system architecture. This allows throughput scaling without compromising packing quality or creating channeling issues

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Reliability

If conventional chromatographic resins are used, then separation based on ionic groups, size, hydrophobic interaction, or affinity can be achieved, but selective removal of viruses and neutral/negatively charged biomaterials is insufficient

Engineering Contradiction:
ImproveselectivityVSAvoidpurification efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention modifies the chemical parameters of the chromatographic medium by functionalizing beads with specific ligands (such as polylysine or other cationic ligands) that exhibit enhanced affinity for neutral and negatively charged biomaterials including viruses. This parameter change enables selective capture that was not achievable with conventional resins

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite chromatographic beads combining a porous support matrix with grafted ligand layers. This composite structure provides both the mechanical integrity needed for column operation and the specific chemical affinity required for selective virus and neutral biomaterial binding

Inventive Principle:
Principle #40Composite materials

4Manufacturing precision

If absorption operation is shut down upon breakthrough detection, then product quality is maintained, but dynamic capacity is significantly less than static capacity

Engineering Contradiction:
Improveproduct qualityVSAvoidresin utilization
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention performs preliminary functionalization of beads with ligands that provide enhanced and more uniform binding capacity. This preliminary action creates a more robust adsorption medium that can operate closer to its static capacity while maintaining product quality, reducing the gap between dynamic and static capacity

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The multi-cell series arrangement allows continuous operation where the first cells become saturated while subsequent cells remain active. This continuity enables the system to utilize more of the total resin capacity before product quality deteriorates, effectively increasing dynamic capacity utilization

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ligand-functionalized substrates enable efficient and selective capture of target biomaterials like viruses, while minimizing binding of non-target materials, thereby improving purification throughput and reducing operational costs.

Implementation Method 1

exposing the base substrate comprising grafted photoinitiator groups to UV radiation to polymerize the remaining ethylenically unsaturated, free-radically polymerizable groups

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Data Source

PatentUS10017461B2Method of making ligand functionalized substrates
Publication Date: 2018.07.10 SOLVENTUM INTELLECTUAL PROPERTIES CO
  • US10017461B2 patent drawing
  • US10017461B2 patent drawing
  • US10017461B2 patent drawing

AI summary

Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.